ArticleNeuroradiology2026
Effect of personalized blood pressure management during mechanical thrombectomy under general anesthesia: a single-center before-after study.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBlood pressure (BP) variability, particularly arterial hypotension during mechanical thrombectomy (MT) for acute ischemic stroke (AIS), has been associated with unfavorable outcomes. This variability in BP is notably present during induction in general anesthesia (GA). This study seeks to assess the effectiveness of a personalized BP management protocol during MT under general GA in mitigating hypotension and its impact on functional outcomes at 90 days.
methodsWe conducted a monocentric before-after study involving two retrospective cohorts of patients who underwent MT for AIS under GA, before and after implementing the protocol. The protocol aimed to maintain the mean arterial pressure (MAP) within 10% of the baseline MAP prior to induction. The main outcome measured was the modified Rankin Scale (mRS) at 90 days.
resultsOur analysis included 179 patients: 121 before and 58 after protocol implementation. The "after" group showed a reduced proportion of MAP drops, especially severe hypotension (32.8% vs. 48.8% below 30% from baseline, and 51.7% vs. 66.1% below 20%). However, these differences lacked statistical significance. At 90 days, a poor outcome (mRS > 2) was observed in 56.9% of patients in the 'after' group vs. 46.3% in the 'before' group, not statistically significant. This association remained statistically insignificant in both univariate and multivariate analyses.
conclusionThe personalized BP management during MT resulted in a decrease in BP drops without reaching significance. Furthermore, this study did not indicate any improvement in neurological outcomes at 90 days.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.